Rallis India's wholly-owned subsidiary Metahelix Life Sciences Ltd (Metahelix) would have 49 per cent stake in the JV firm PT Metahelix Lifesciences Indonesia, which would have an initial paid up capital of USD 1,25,000 and the same would be doubled by March 2017.
In a filing to the BSE today, Rallis India said that Metahelix has "entered into a joint venture with Indonesian local partner Suresh Gobindram Vaswani for the establishment of a seed production and/o distribution company, viz. PT Metahelix Lifesciences Indonesia".
"The current paid up capital of the JV entity is USD 1,25,000, to be increased to USD 2,50,000 by March 2017. Metahelix and the JV partner will invest in the paid up capital to the extent of their share in the JV, viz, 49 per cent and 51 per cent, respectively," Rallis India said.
The joint venture firm would engage in the activity of seed production, processong and/or packing, importing or purchasing parent seeds and distributing and trading of JV seeds under any distribution model within Indonesia.
Rallis India, a Tata enterprise, is a leading player in the Indian crop protection industry.